Skip to main content
All lobbying filings

ZIMMER BIOMET, INC.

Lobbying for ZIMMER BIOMET, INC.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $185,000.00 expenses · posted Apr 19, 2026

Official filing document

 Lobbying activity 6
Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Physician Fee Schedule

Trade (domestic/foreign)

Trade Issues/Policy, Tariffs

Taxation/Internal Revenue Code

Tax Issues; Enhanced ACA Tax Credit

Chemicals/Chemical Industry

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

Medical/Disease Research/Clinical Labs

Breakthrough devices;

Science/Technology

e-labeling; Breakthrough devices

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem